Scottish biotech ProStrakan sold for £292m
Scottish biotech ProStrakan is to be bought by Japanese manufacturer Kyowa Hakko Kirin for £292 million.The companies agreed the deal this week, with KHK paying 130p per share for the Galshiels...
View ArticleNew $50m plant unveiled by Kyowa Hakko Kirin
Japan's Kyowa Hakko Kirin is to build a new manufacturing unit for oral formulations at its main production facility in Ube.The 4 billion-yen ($50m) project is part of a wider reorganisation of Kyowa...
View ArticleBMS to trial Opdivo in solid tumours
Bristol-Myers Squibb will begin early-phase trials of its immuno-oncology treatment Opdivo with other cancer treatments, to see if the combination can treat people with advanced solid tumours.BMS it...
View ArticleKyowa Hakko Kirin signs drug discovery deal with AI firm InveniAI
Japanese pharma and biotech firm Kyowa Hakko Kirin is joining the growing trend of investing in artificial intelligence to bolster drug discovery efforts, entering a new partnership with AI and machine...
View Article
